Cardiovascular risk in overweight/obese and lean hypertensive patients

被引:3
|
作者
Neves, Ana Luisa [1 ,2 ]
Couto, Luciana [2 ]
机构
[1] Univ Porto, Abel Salazar Biomed Sci Inst, GABBA Program, P-4100 Oporto, Portugal
[2] Univ Porto, Dept Social Sci & Hlth, Family Med Unit, P-4100 Oporto, Portugal
关键词
Cardiovascular risk; Obesity; Overweight; Arterial hypertension; ORGAN DAMAGE; OBESITY; DISEASE; PREVALENCE;
D O I
10.1016/j.repc.2013.10.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Obesity and hypertension have been identified as independent risk factors for Obesity; cardiovascular disease. Nevertheless, the role of obesity in the development and progression of Overweight; target-organ disease in hypertensive patients is controversial. The objective of this study was Arterial hypertension to assess the impact of body weight on cardiovascular risk factors, target-organ disease and global cardiovascular risk in hypertensive patients in a primary care setting. Methods: A cross-sectional observational study was carried in Vila Nova de Gaia, Portugal (n=150). A detailed medical and personal history was obtained and a physical examination was performed. Venous blood and 24-hour urine samples were collected, and an electrocardiogram was performed. Cardiovascular risk was assessed using the Framingham score. The statistical analysis was performed using SPSS (R). A p-value <0.05 was considered statistically significant. Results: The sample was 71.8% female, with a mean age of 74.3 +/- 10.8 years. The prevalence of obesity was 29.5%. Overweight/obese subjects presented lower mean HDL cholesterol (51.2 +/- 13.9 mg/dl vs. 65.4 +/- 35.2, p<0.005), higher triglycerides (137.8 +/- 70.4 mg/dl vs. 111.5 +/- 68.8 mg/dl, p<0.001), higher fasting glucose (111.9 +/- 32.8 mg/dl vs. 98.4 +/- 13.1 mg/dl, p<0.011) and more frequent mild valve disease (57.9% vs. 29.6%, p=0.021). Global cardiovascular risk was also significantly higher (10.9 +/- 7.7 vs. 6.5 +/- 5.7, p<0.001). Conclusion: Overweight and obesity appear to be related to a less favorable lipid and blood glucose profile and higher cardiovascular risk in hypertensive patients. On the basis of our findings we suggest strict metabolic monitoring and improved education on weight reduction and control at primary health care clinics. (C) 2011 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:223 / 228
页数:6
相关论文
共 50 条
  • [41] Correlations between surrogate measures of insulin resistance and cardiovascular risk factors in obese and overweight patients
    Lerman, I
    Villa, AR
    Torres, JMR
    Tamez, LE
    Pérez, FG
    Velasco, SLD
    Rodrigo, JAR
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2003, 17 (02) : 66 - 72
  • [42] Survey of Cardiovascular Risk Factors in Overweight and Obese Patients (SCOOP Study) Six-month changes in risk factor levels and cardiovascular risk
    Iori, Ido
    Fatati, Giuseppe
    Fusco, Maria Antonia
    Leonardi, Francesco
    Matthieu, Giovanni
    Scanelli, Giovanni
    Lanti, Mariapaola
    Menotti, Alessandro
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2009, 20 (03) : 280 - 288
  • [43] CLINICAL AND HEMODYNAMIC-EFFECTS OF KETANSERIN IN LEAN AND OBESE HYPERTENSIVE PATIENTS
    LICATA, G
    SCAGLIONE, R
    PARRINELLO, G
    CAPUANA, G
    MAZZOLA, G
    LIPARI, R
    CASTELLO, R
    GALANTINO, L
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1990, 18 (02) : 112 - 119
  • [44] OBESE HYPERTENSIVE PATIENTS ARE LESS EFFECTIVELY TREATED THAN LEAN HYPERTENSIVES
    SCHMIEDER, RE
    GATZKA, C
    KLINGBEIL, A
    RUDDEL, H
    SCHACHINGER, H
    TENESREINO, S
    JOURNAL OF HYPERTENSION, 1993, 11 : S348 - S349
  • [45] Contrasting clinical properties and exercise responses in obese and lean hypertensive patients
    Weber, MA
    Neutel, JM
    Smith, DHG
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (01) : 169 - 174
  • [46] Six-week treatment with sibutramine in hypertensive obese/overweight patients with high cardiovascular risk reduces blood pressure-an analysis of the sibutramine cardiovascular outcomes (SCOUT) trial
    Torp-Pedersen, C.
    Caterson, I.
    Coutinho, W.
    Finer, N.
    Van Gaal, L.
    Maggioni, A.
    Sharma, A. M.
    James, W. P. T.
    EUROPEAN HEART JOURNAL, 2007, 28 : 870 - 870
  • [47] ARE LEAN HYPERTENSIVES AT GREATER RISK OF CARDIOVASCULAR MORTALITY THAN OBESE HYPERTENSIVES
    CARMAN, WJ
    BARRETTCONNOR, E
    SOWERS, M
    KHAW, KT
    CIRCULATION, 1992, 85 (02) : 866 - 866
  • [48] Orlistat in hypertensive overweight/obese patients: results of a randomized clinical trial
    Bloch, KV
    Salles, GF
    Muxfeldt, ES
    Nogueira, ADR
    JOURNAL OF HYPERTENSION, 2003, 21 (11) : 2159 - 2165
  • [49] Prediabetes and cardiovascular risk in hypertensive patients
    Julian Segura
    Cecilia Roldän
    Jose A. García-Donaire
    Luis M. Ruilope
    Current Hypertension Reports, 2006, 8
  • [50] Cardiovascular Risk Assessment in Hypertensive Patients
    Wang, Michael C.
    Lloyd-Jones, Donald M.
    AMERICAN JOURNAL OF HYPERTENSION, 2021, 34 (06) : 569 - 577